(Total Views: 409)
Posted On: 12/21/2019 9:34:44 AM
Post# of 155147
Quote:
Adding some financial analysys would be helpful may be in a separate sticky?
Yeah, I thought about that too yesterday, because I thought this should be Leronlimab Cliff Notes, not fully CytoDyn. I suspect the financial situation will improve now that sp has reacted positivity, because it has with other companies I have followed. It is amazing, no one wants to be a part when sp is dropping, but sp trend up, people want to jump in. I will wait until January, we should get 10Q soon after, 1st week or so, but I suspect other positive financial possibilities will happen soon if history in other stock repeats when sp spiked for them like it did last week for us. Normally in biotech, the spike like that is followed my an offering, but they raised money right before and with the 4.5M from the deal, hopefully that gives them enough time to raise in a different manner--another licensing deal for HIV non-US or NASH for example, or if with shares at least on much better terms than last time.
(1)
(0)
